Karam El-Bayoumy Selected Research

selenocyanic acid (selenocyanate)

7/2006	Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.
7/2004	Mechanisms of mammary cancer chemoprevention by organoselenium compounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karam El-Bayoumy Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 01/2002
32	Carcinogenesis 01/2022 - 03/2002
22	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2002
13	Prostatic Neoplasms (Prostate Cancer) 08/2014 - 11/2002
8	Lung Neoplasms (Lung Cancer) 09/2015 - 01/2003
6	Mouth Neoplasms (Oral Cancer) 01/2022 - 08/2011
6	Inflammation (Inflammations) 01/2021 - 12/2010
5	Squamous Cell Carcinoma of Head and Neck 01/2021 - 09/2013
4	Adenocarcinoma 10/2007 - 07/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 07/2014
3	Carcinoma (Carcinomatosis) 01/2012 - 04/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2009 - 03/2002
2	Hyperplasia 01/2021 - 03/2005
2	Oral Leukoplakia 01/2019 - 12/2017
2	Obesity 12/2017 - 04/2016
2	Metaplasia 09/2015 - 03/2005
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2015 - 03/2011
2	Neoplasm Metastasis (Metastasis) 01/2012 - 12/2005
2	Prostatic Intraepithelial Neoplasia 08/2010 - 04/2009
1	Papillomavirus Infections 01/2021
1	Infections 01/2021
1	Papilloma (Papillomatosis) 01/2021
1	Lung Injury 01/2021
1	Chronic Disease (Chronic Diseases) 01/2020

Drug/Important Bio-Agent (IBA)

20	SeleniumIBA 08/2014 - 11/2002
16	dibenzo(a,l)pyreneIBA 01/2022 - 08/2011
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
14	SmokeIBA 01/2022 - 03/2005
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2003
13	1,4-phenylenebis(methylene)selenocyanateIBA 11/2012 - 03/2002
11	CarcinogensIBA 01/2021 - 01/2002
10	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020 - 03/2010
9	Fish OilsIBA 01/2020 - 03/2010
8	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 04/2004
8	Tamoxifen FDA LinkGeneric 04/2016 - 03/2010
7	DNA AdductsIBA 01/2022 - 10/2003
6	Biological ProductsIBA 01/2021 - 08/2009
6	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 07/2002
6	Hormones (Hormone)IBA 01/2015 - 01/2002
5	Epoxy Compounds (Epoxides)IBA 01/2018 - 02/2003
5	Selenomethionine (Sethotope)FDA Link 08/2014 - 01/2003
5	Glutathione (Reduced Glutathione)IBA 03/2010 - 09/2003
5	Organoselenium CompoundsIBA 01/2008 - 09/2003
4	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022 - 01/2011
4	Docosahexaenoic AcidsIBA 11/2021 - 02/2015
4	AndrogensIBA 11/2012 - 04/2007
4	anthraceneIBA 01/2006 - 09/2003
3	Environmental CarcinogensIBA 01/2020 - 01/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 04/2014
3	Estrogen Receptor Modulators (Antiestrogen)IBA 04/2016 - 03/2010
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2015 - 02/2007
3	Estrogen ReceptorsIBA 01/2015 - 12/2005
3	Androgen Receptors (Androgen Receptor)IBA 11/2012 - 12/2005
3	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2012 - 03/2010
3	SulfurIBA 03/2010 - 01/2006
3	AntioxidantsIBA 03/2010 - 03/2005
2	Benzo(a)pyreneIBA 01/2022 - 01/2006
2	4-oxo-5,7,10,13,16,19-docosahexaenoic acidIBA 11/2021 - 02/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2012
2	dibenzo(a,l)pyrene diol epoxideIBA 01/2021 - 01/2018
2	GelsolinIBA 01/2019 - 09/2013
2	trans-1,2-dihydro-1,2-naphthalenediolIBA 12/2017 - 08/2011
2	pyreneIBA 01/2017 - 09/2013
2	AcidsIBA 05/2016 - 01/2006
2	Raloxifene Hydrochloride (Evista)FDA Link 04/2016 - 01/2015
2	Vitamin D-Binding ProteinIBA 06/2015 - 09/2013
2	Estrogens (Estrogen)FDA Link 11/2011 - 08/2002
2	Corn Oil (Oil, Corn)IBA 08/2011 - 02/2007
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2011 - 12/2008
2	Prostate-Specific Antigen (Semenogelase)IBA 09/2010 - 04/2007
2	LigandsIBA 03/2010 - 12/2008
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 09/2009 - 07/2002
2	NitrosaminesIBA 08/2009 - 06/2006
2	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 05/2009 - 12/2007
2	nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 07/2008 - 01/2003
2	selenocyanic acid (selenocyanate)IBA 07/2006 - 07/2004
2	8-Hydroxy-2'-DeoxyguanosineIBA 06/2006 - 07/2002
2	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 06/2006 - 01/2003
2	Selenium CompoundsIBA 01/2006 - 07/2004
2	7,12-dimethylbenz(a)anthracene-DNA adduct (DMBA-DNA adduct)IBA 01/2006 - 07/2004
2	Complementary DNA (cDNA)IBA 07/2004 - 09/2003
2	6-nitrochryseneIBA 04/2004 - 07/2002
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021
1	15-hydroxyprostaglandin dehydrogenaseIBA 11/2021
1	Lipoxygenase (Lipoxygenase-1)IBA 11/2021
1	Dinoprostone (PGE2)FDA Link 11/2021
1	Viral DNAIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	AerosolsIBA 01/2021
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2021
1	Delta CateninIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Nicotine FDA Link 01/2021
1	SolventsIBA 01/2021
1	Glycerol (Glycerine)FDA LinkGeneric 01/2021

Therapy/Procedure

17	Chemoprevention 01/2022 - 03/2002
3	Oral Administration 02/2005 - 07/2002
2	Therapeutics 11/2012 - 07/2009
1	Secondary Prevention 01/2020